Common CAPA Mistakes in Pharma and How to Avoid Them
Introduction In pharmaceutical manufacturing, CAPA (Corrective and Preventive Action) is one of the most critical quality processes for maintaining compliance, product safety, and continuous improvement. Regulatory agencies such as the FDA, WHO-GMP, MHRA, and EU GMP closely examine CAPA records during inspections because they reflect how effectively a company identifies and resolves quality issues. However, […]
How CAPA Management Software Improves Root Cause Analysis in Pharma
Introduction In pharmaceutical manufacturing, deviations, quality incidents, and compliance failures can have serious consequences—ranging from batch rejection to FDA warning letters. Identifying the issue is only the first step. The real challenge lies in understanding why the issue occurred and preventing it from happening again. This is where Root Cause Analysis (RCA) becomes a critical […]
Top 15 FDA Audit Findings Related to 21 CFR Part 11 and How to Avoid Them
FDA inspections continue to reveal recurring compliance gaps related to electronic records, electronic signatures, audit trails, and data integrity. While many pharmaceutical companies have implemented digital systems, regulators frequently identify weaknesses in how these systems are configured, validated, monitored, and controlled. The objective of 21 CFR Part 11 is not simply to digitize records but […]
